UCI Health is pleased to announce a mobile wayfinding tool designed to make step-by-step navigation at UCI Medical Center simple for patients and visitors. UCI Health Find My Way, based on Connexient’s MediNav technology, is fully integrated into the health system’s My UCI Health app for Android- and iOS-based mobile…
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
In Phase II trial, treatment inhibited key enzyme, resulting in lowered triglyceride production and slower progression of non-alcoholic fatty liver disease to its more dangerous form: non-alcoholic steatohepatitis
Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.
Launched in 2002, the Vietnam Era Twin Study of Aging will continue to follow and document risk and protective factor for cognitive and brain aging in 1,600 male twins
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
Deleting an inhibitory gene in natural killer cells derived from induced pluripotent stem cells is found to boost their anti-tumor activity and persistence; researchers now seek to develop a clinical therapy
IN THE NEWS: Dr. Nasim Afsar, chief operating officer for ambulatory care for UCI Health, is recognized as one of Orange County's leading women in healthcare by Coast Magazine and the Orange County Register. Afsar always knew that her life would be about providing health care to communities with the…
Health Media Contacts
Find the best contact for health-related media inquiries.
